Literature DB >> 3825507

Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin.

B Schwerer, H Lassmann, K Kitz, H Bernheimer.   

Abstract

Ganglioside-antisera, the ganglioside GM1-ligands, cholera toxin (CT), and CT subunit B, respectively, were injected into the lumbosacral subarachnoid space of normal rats. The cytotoxic effects of the injected compounds on the peripheral and central nervous system were investigated by light and electron microscopy; the severity of CNS lesions was evaluated by quantitation of macrophages containing debris. In contrast to control sera and GM2-antiserum, antisera against a mixture of the major brain gangliosides GM1, GD1a, GD1b, and GT1b (MaBG) or against GM1 induced demyelination in spinal roots and spinal cord, as well as alterations of astroglia. CT induced the same cytotoxic effects as MaBG- and GM1-antisera, whereas CT subunit B was without effect. The ineffectiveness of GM2-antiserum is obviously due to the very low concentration of the specific binding target, GM2, on cell surfaces; that of CT subunit B to the lack of the cytotoxic operator, subunit A. Our results indicate that a similar pattern of neuropathological lesions may be effected by different cytotoxic mechanisms through attachment of the cytotoxic agent onto the cell surface via a common target molecule, and further substantiate the role of GM1-antibodies in the pathogenesis of demyelination.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3825507     DOI: 10.1007/bf00687947

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  32 in total

1.  Restoration of activity for induction of experimental allergic peripheral neuritis by a combination of myelin basic protein P2 and gangliosides from peripheral nerve.

Authors:  Y Nagai; T Uchida; S Takeda; F Ikuta
Journal:  Neurosci Lett       Date:  1978-06       Impact factor: 3.046

2.  The isolation and lipid composition of myelin-free axons from rat CNS.

Authors:  G H De Vries; M G Hadfield; C Cornbrooks
Journal:  J Neurochem       Date:  1976-04       Impact factor: 5.372

3.  Immunochemical studies of isolated human brain ganglioside components.

Authors:  T A Pascal; A Saifer
Journal:  J Neurochem       Date:  1969-03       Impact factor: 5.372

Review 4.  The chemistry and biology of cholera toxin.

Authors:  C Y Lai
Journal:  CRC Crit Rev Biochem       Date:  1980

5.  Isolated leptomeninges of the spinal cord: an ideal tool to study inflammatory reaction in EAE.

Authors:  K Kitz; H Lassmann; H M Wisniewski
Journal:  Acta Neuropathol Suppl       Date:  1981

6.  Ganglioside receptors and induction of epileptiform activity: cholera toxin and choleragenoid (B subunits).

Authors:  S E Karpiak; S P Mahadik; M M Rapport
Journal:  Exp Neurol       Date:  1978-10       Impact factor: 5.330

7.  Immunochemical reactions of lipids.

Authors:  M M Rapport; L Graf
Journal:  Prog Allergy       Date:  1969

8.  Humoral immune responses to myelin basic protein, cerebroside and ganglioside in chronic relapsing experimental allergic encephalomyelitis of the guinea pig.

Authors:  T Tabira; M Endoh
Journal:  J Neurol Sci       Date:  1985-02       Impact factor: 3.181

9.  Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides.

Authors:  Y Nagai; T Momoi; M Saito; E Mitsuzawa; S Ohtani
Journal:  Neurosci Lett       Date:  1976-04       Impact factor: 3.046

10.  Antiserum to brain gangliosides produces recurrent epileptiform activity.

Authors:  S E Karpiak; L Graf; M M Rapport
Journal:  Science       Date:  1976-11-12       Impact factor: 47.728

View more
  15 in total

1.  Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection.

Authors:  B Schwerer; A Neisser; H Bernheimer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Guillain-Barré syndrome associated with normal or exaggerated tendon reflexes.

Authors:  Nobuhiro Yuki; Norito Kokubun; Satoshi Kuwabara; Yukari Sekiguchi; Masafumi Ito; Masaaki Odaka; Koichi Hirata; Francesca Notturno; Antonino Uncini
Journal:  J Neurol       Date:  2011-12-06       Impact factor: 4.849

3.  Ganglioside spinal cord changes in chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rats.

Authors:  E Zaprianova; D Deleva; B Hauttecoeur; M Bakalska; A Filchev
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

Review 4.  Antiglycolipid antibodies in peripheral neuropathy: fact or fiction?

Authors:  H J Willison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

5.  Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody.

Authors:  S Kuwabara; K Ogawara; M Koga; M Mori; T Hattori; N Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

6.  Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides.

Authors:  J C Garcia-Monco; R J Seidman; J L Benach
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier.

Authors:  F P Thomas; W Trojaborg; C Nagy; M Santoro; S A Sadiq; N Latov; A P Hays
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Cerebrospinal fluid antiganglioside antibodies in patients with AIDS.

Authors:  M Sorice; T Griggi; A Circella; G Nicodemo; M Ciardi; C M Mastroianni; L Lenti; F Sorice
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

9.  In vivo CNS demyelination mediated by anti-galactocerebroside antibody.

Authors:  K Ozawa; T Saida; K Saida; H Nishitani; M Kameyama
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 10.  Endocytosis of glycosylphosphatidylinositol-anchored proteins.

Authors:  Shaheen E Lakhan; Shefali Sabharanjak; Ananya De
Journal:  J Biomed Sci       Date:  2009-10-15       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.